We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$40.1B
AUM Growth
+$8.37B
(+26%)
Cap. Flow
+$13B
Cap. Flow
% of AUM
32.41%
Top 10 Holdings %
Top 10 Hldgs %
27.27%
Holding
5,081
New
1,977
Increased
1,066
Reduced
622
Closed
1,387
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$621M |
| 2 |
SNDK
Sandisk
SNDK
|
+$467M |
| 3 |
AbbVie
ABBV
|
+$205M |
| 4 |
Valero Energy
VLO
|
+$150M |
| 5 |
SoFi Technologies
SOFI
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$599M |
| 2 |
NVIDIA
NVDA
|
+$468M |
| 3 |
Applied Materials
AMAT
|
+$306M |
| 4 |
Apple
AAPL
|
+$280M |
| 5 |
Micron Technology
MU
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.83% |
| 2 | Financials | 6.27% |
| 3 | Industrials | 4.73% |
| 4 | Healthcare | 4.21% |
| 5 | Energy | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNTX
3576
Rein Therapeutics
RNTX
$66.9M
| $20K | ﹤0.01% |
15,486
-17,751
| -53% | -$22K |
|
3577
Castellum
CTM
$63.7M
| $19K | ﹤0.01% |
+33,836
| New | +$30.2K |
|
|
EM
3578
DELISTED
Smart Share Global Ltd
EM
| $19K | ﹤0.01% |
17,139
+2,513
| +17% | +$2.88K |
|
|
ONCY
3579
Oncolytics Biotech
ONCY
$95.5M
| $19K | ﹤0.01% |
23,256
+11,263
| +94% | +$11.2K |
|
|
ENGS
3580
Energys Group
ENGS
$85M
| $19K | ﹤0.01% |
+16,261
| New | +$15.5K |
|
|
IQST
3581
IQSTEL Inc
IQST
$6.8M
| $19K | ﹤0.01% |
+12,055
| New | +$27.6K |
|
3582
Loop Industries
LOOP
$37.3M
| $18K | ﹤0.01% |
+12,593
| New | +$15.8K |
|
|
PMAX
3583
Powell Max Ltd
PMAX
$2.69M
| $18K | ﹤0.01% |
5,960
+4,723
| +382% | +$84.5K |
|
3584
Celularity
CELU
$21.7M
| $17K | ﹤0.01% |
+12,784
| New | +$16.2K |
|
3585
Entera Bio
ENTX
$193M
| $17K | ﹤0.01% |
+15,492
| New | +$21.7K |
|
3586
Freight Technologies
FRGT
$1.69M
| $17K | ﹤0.01% |
+4,218
| New | +$27.8K |
|
|
SEGG
3587
Sports Entertainment Gaming Global Corp
SEGG
$14.4M
| $17K | ﹤0.01% |
+27,963
| New | +$30.7K |
|
|
NVVE
3588
DELISTED
Nuvve Holding Corp
NVVE
| $17K | ﹤0.01% |
+1,490
| New | +$44.7K |
|
3589
SOBR Safe
SOBR
$1.75M
| $17K | ﹤0.01% |
+35,014
| New | +$39.4K |
|
3590
Wetouch Technology
WETH
$15.5M
| $17K | ﹤0.01% |
+14,389
| New | +$23K |
|
3591
Clearmind Medicine
CMND
$2.41M
| $16K | ﹤0.01% |
+1,591
| New | +$24.6K |
|
3592
PharmaCyte Biotech
PMCB
$6.28M
| $16K | ﹤0.01% |
24,741
-158,060
| -86% | -$121K |
|
3593
VYNE Therapeutics
VYNE
$19.1M
| $16K | ﹤0.01% |
+551
| New | +$16.1K |
|
|
LHSW
3594
Lianhe Sowell International Group
LHSW
$7.51M
| $16K | ﹤0.01% |
+6,726
| New | +$44.2K |
|
3595
Curis
CRIS
$9.14M
| $15K | ﹤0.01% |
+1,416
| New | +$26.4K |
|
3596
Marker Therapeutics
MRKR
$20.3M
| $15K | ﹤0.01% |
11,852
-2,085
| -15% | -$3.31K |
|
|
AIM
3597
AIM ImmunoTech
AIM
$6.93M
| $15K | ﹤0.01% |
+26,032
| New | +$26.4K |
|
|
ETS
3598
Elite Express Holding Inc
ETS
$52.1M
| $15K | ﹤0.01% |
+22,204
| New | +$11.6K |
|
|
CREG
3599
DELISTED
Smart Powerr
CREG
| $14K | ﹤0.01% |
+5,565
| New | +$60.8K |
|
3600
Werewolf Therapeutics
HOWL
$22M
| $14K | ﹤0.01% |
+17,861
| New | +$12.2K |
|
Similar funds
HRT Financial's Q1 2026 Portfolio in Review
As of Q1 2026, HRT Financial held 5,081 positions worth $40.1B, up 26% from $31.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
HRT Financial deployed $13B of net new capital in Q1 2026, opening 1,977 new positions and adding to 1,066 existing holdings. Its largest new stake was AbbVie: 926,410 shares worth $201M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Broadcom, an estimated $599M trimmed.
- HRT Financial's largest Q1 2026 buy was AbbVie: 926,410 shares worth $201M.
- HRT Financial added most to Invesco QQQ Trust in Q1 2026, an estimated $621M increase.
- HRT Financial's biggest Q1 2026 reduction was Broadcom, cutting an estimated $599M.
- HRT Financial fully exited NVIDIA in Q1 2026, selling an estimated $468M.
- HRT Financial's ten largest holdings make up 27% of its $40.1B portfolio in Q1 2026.
- HRT Financial opened 1,977 new positions and closed 1,387 in Q1 2026.
- HRT Financial's portfolio value rose 26% quarter-over-quarter to $40.1B.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.